Trials / Completed
CompletedNCT02287870
Epidural Anesthesia With Chloroprocaine Versus Lidocaine
Low Epidural Anesthesia With Chloroprocaine Versus Lidocaine: a Prospective, Randomized, Double-blinded Multi-centre Clinical Trial in China
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Jinling Hospital, China · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Chinese made chloroprocaine has a rapid onset time, effective methodology, can last for a short time, provides fast motor recovery and causes no significant side effects.
Detailed description
Chloroprocaine hydrochloride is the chloridized local anesthetic of procaine hydrochloride, with twice the anesthetic intensity, four to five times the metabolization and half the side effect of procaine. The chloroprocaine hydrochloride product made in China has been on sale since 2002. To determine the clinical efficacy of low-epidural anesthesia with chloroprocaine versus lidocaine, the investigators carried out a prospective, randomized, double-blinded multi-centre clinical trial. The results demonstrate that epidural anesthesia using chloroprocaine has a more rapid onset time and shorter duration than with lidocaine. It can also provide a reliable sensory and motor block in epidural anesthesia, and is thus a more attractive alternative than lidocaine for middle and short duration surgical procedures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chloroprocaine | 60 patients undergoing lower limb or lower abdominal surgery from three hospitals in China received 3% chloroprocaine. |
| DRUG | Lidocaine | 60 patients undergoing lower limb or lower abdominal surgery from three hospitals in China received 2% lidocaine. |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2008-04-01
- Completion
- 2008-06-01
- First posted
- 2014-11-11
- Last updated
- 2014-11-11
Source: ClinicalTrials.gov record NCT02287870. Inclusion in this directory is not an endorsement.